KMT2D c.12334_12335delinsTT ;(p.G4112F)

Variant ID: 12-49426153-CC-AA

NM_003482.3(KMT2D):c.12334_12335delinsTT;(p.G4112F)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson's Disease via Bioinformatics Analysis.

Parkinson'S Disease
Zhou, Yunan Y; Li, Zhihui Z; Chi, Chunling C; Li, Chunmei C; Yang, Meimei M; Liu, Bin B
Publication Date: 2023

Variant appearance in text: KMT2D: G4112F
PubMed Link: 37089789
Variant Present in the following documents:
  • PD2023-6755569.pdf
View BVdb publication page



Comprehensive Analysis of Aberrantly Expressed Competitive Endogenous RNA Network and Identification of Prognostic Biomarkers in Pheochromocytoma and Paraganglioma.

Oncotargets And Therapy
Wang, Zijun Z; Li, Yijian Y; Zhong, Yanjun Y; Wang, Yinhuai Y; Peng, Mou M
Publication Date: 2020

Variant appearance in text: KMT2D: G4112F
PubMed Link: 33192072
Variant Present in the following documents:
  • Main text
View BVdb publication page



VEGF121, is predictor for survival in activated B-cell-like diffuse large B-cell lymphoma and is related to an immune response gene signature conserved in cancers.

Oncotarget
Broséus, Julien J; Mourah, Samia S; Ramstein, Gérard G; Bernard, Sophie S; Mounier, Nicolas N; Cuccuini, Wendy W; Gaulard, Philippe P; Gisselbrecht, Christian C; Brière, Josette J; Houlgatte, Rémi R; Thieblemont, Catherine C
Publication Date: 2017-10-31

Variant appearance in text: KMT2D: G4112F
PubMed Link: 29207605
Variant Present in the following documents:
  • Main text
  • oncotarget-08-90808.pdf
View BVdb publication page